Executive Summary
OneDrop combines algorithmic personalization with standardized industrial production to serve the Italian supplements market — over €4.5B and 30 million consumers.
The operating model is asset-light and scalable: the personalization logic lives in software (quiz, algorithm, UX), while physical production relies on standardized modules (nutrient clusters in single-dose stick packs), each notified as a standalone supplement and manufactured by certified CDMOs.
This approach enables a highly personalized experience while avoiding the regulatory and operational complexity of fully custom formulations — maintaining regulatory compliance, operational simplicity, and economic scalability.
Strategic Positioning
OneDrop is positioned in the DTC subscription segment, serving two initial beachheads:
Initial wedge: Strength training + CrossFit/functional — high practice incidence, high usage propensity, and an immediately communicable pain point.
Unit Economics (base scenario)
Software personalizes · industry standardizes · logistics combines.
This makes the model defensible and investable from the earliest stages.
Quantified Pain · Unit Logic · Path to Scale
Concrete data behind the problem, the business model, and why this scales.
The pain is real — and quantified
The problem isn't a lack of supplements — there are too many. 33% of Italian consumers already manage 2+ types. Among gym-goers, 81% use supplements but buy from 3–5 different brands, in different forms, with no certainty about compatibility and dosages. They already spend €50–120/month. OneDrop doesn't create demand: it reorganizes it into a simpler system.
Unit economics — every assumption is explicit
| Item | Value | Source / Assumption |
|---|---|---|
| Subscription price | €69/mese | Bioniq GO (~$75) — AG1 (~€87) corridor |
| COGS (raw materials + blending + stick pack) | ~€12–15/mese | CDMO Italy benchmark, 5k–10k unit batches |
| Packaging + kitting + shipping | ~€6–8/mese | Monthly box + 3PL Italy, initial volumes |
| Gross margin | ~€46 → ~67% | Target >70% at scale with batch optimization |
| CAC (blended) | €80–120 | Meta/Google ads + influencer performance |
| Monthly churn (target) | 7% | DTC health subscription benchmark |
| LTV (margin) | ~€660 | €46 margin × 14.3 months (1 / churn) |
| LTV:CAC | 5,5–8,3x | Range €80–€120 CAC |
| Payback | ~2 months | €100 CAC / €46 monthly margin |
Even with stressed churn and CAC (12% and €150), the model remains >2.7x LTV:CAC. The ~2-month payback enables rapid reinvestment in growth.
Path to scale — how personalization stays lean
OneDrop is not "hyper-personalization" — it's smart modular customization. Personalization is in software; production is industrial.
In practice: 8 clusters → 56+ possible personalized combinations → 1 single standard production process.
Each new cluster multiplies combinations without multiplying costs.
Personalization is perceived as infinite, but operationally finite.
Operational & Production Model
OneDrop adopts an asset-light, scalable, and regulatory-solid production model based on separating personalization logic (software) from physical production (standardized, certified, and notified modules).
Product architecture: modular cluster system
The OneDrop product is not a single variable formula, but a modular system composed of nutrient clusters, each represented by a single-dose powder sachet (stick pack). Each cluster is designed for a specific functional goal.
Each cluster has a fixed and validated composition, is produced and packaged separately, and is regulatory-notified as a standalone food supplement. The algorithm assigns 1–3 daily clusters, creating an experience perceived as personalized on a standardized industrial structure.
Production: contract manufacturing (CDMO)
Production is fully outsourced to specialized contract manufacturers (CDMO), located in Italy or Europe, already authorized for food supplement production.
- Procurement of certified raw materials
- Blending of formulations
- Single-dose stick pack filling
- Quality controls (microbiological and chemical)
- Batch traceability and documentation
- HACCP compliance and food standards
- Zero industrial CAPEX
- Reduced operational risk
- Rapid production scaling
- Focus on software and brand
End-to-end operational flow
Strategic model advantages
Why not fully custom formulas
A 1:1 model (one formula per customer) is extremely complex at the regulatory level, requires on-demand production, destroys economies of scale, and increases operational risk.
OneDrop solves this problem with algorithmic personalization on standardized modules.
Future evolution
In the medium term, the system can evolve toward greater cluster granularity, advanced technologies (e.g. microgranules), and semi-custom production at higher volumes. In the initial phase, the priority is: speed, market validation, and sustainable unit economics.
Software personalizes · industry standardizes · logistics combines.
Regulatory compliance, operational simplicity, economic scalability.
Target Market Analysis
Italian and European supplements market, TAM/SAM/SOM sizing for the two beachheads, and DTC/subscription benchmarks.
Italy is Europe's #1 market (~26% of continental revenue). Over 73% of the population used supplements in the past year and 33% use two or more types — the "stacking" problem OneDrop solves.
European market
The European VDS market is estimated at ~€16.5B (2023) with a CAGR of ~4.1%. 44% of the EU population practices sports at least weekly and 26% does resistance training — the most relevant segment for OneDrop.
TAM / SAM / SOM — Italy
OneDrop-addressable estimates at €69/month, based on ISTAT data and online propensity per segment. 3-year SOM: <1% of SAM.
| Segment | Estimated users | TAM (ARR) | SAM (online) | SOM (3 years) |
|---|---|---|---|---|
| A Sports stackers | 877.161 | €726,3M | €326,8M | €3,3M |
| B Women 30–45 beauty | 780.000 | €645,8M | €226,0M | €1,8M |
| Total | 1.657.161 | €1.372,1M | €552,9M | €5,1M |
TAM / SAM / SOM — European Union
| Segment | Estimated users | TAM (ARR) | SAM (online) | SOM (3 years) |
|---|---|---|---|---|
| A Sports stackers | 5.053.488 | €4.184,3M | €1.673,7M | €8,4M |
| B Women 30–45 beauty | 5.496.000 | €4.550,7M | €1.456,2M | €5,8M |
| Total | 10.549.488 | €8.735,0M | €3.129,9M | €14,2M |
Segment A: sports stackers
In 2024, >21.5M people in Italy practice sports. Fitness/gymnastics/physical culture is the most common sport with ~7.133M practitioners (33.1%). A systematic review on gym users (24 studies, 9,202 participants) reports ~58% usage. Among amateur bodybuilders, usage reaches 81.3%.
Sub-segments: Strength training (hypertrophy, weight room), Endurance (running/cycling, triathlon), CrossFit/functional (box, HIIT), Recreational athletes (team sports, padel/tennis). Estimated average spend: €50–€120/month (strength), €30–€90/month (endurance).
Micro-personas — Segment A
Segment B: women 30–45 beauty
Among target millennials (26–43), 7 in 10 used supplements last year. Pharmacy remains the main channel (65%), but online is already present: 26% specialized sites + 8.1% brand sites. 23% cite "strengthen hair/skin/nails" among crucial functions. Beauty DTC WTP range: €39–€79/month.
Micro-personas — Segment B
Competitive landscape
The market is hyper-crowded on shelves with pharmacy as the dominant channel. Two competitive clusters are strategically important: pack-based personalization and all-in-one premium.
| Brand | Personalization | Price | Distribution |
|---|---|---|---|
| Bioniq | High (quiz + blood test) | da ~$75/mese | DTC online |
| Nourished | Medium-high (3D-printed) | £35,99/mese | DTC online |
| AG1 | Low (all-in-one) | ~€87/mese | DTC online |
| Multicentrum | Low | €10–25/mese | Pharmacy/Retail |
| Solgar | Low | €15–40/mese | Pharmacy/online |
| Enervit | Low (sports) | €20–100/mese | Sports retail |
| Yamamoto | Low (fitness) | €20–120/mese | Online + stores |
| Viviscal | Low (hair) | €25–60/mese | Pharmacy/online |
| Bioscalin | Low (hair) | €25–70/mese | Pharmacy |
Go-to-Market: pricing and subscription
Mechanics: every 28–30 days cadence, 3-month and annual bundle options, pause/switch formula, and "decline management" to reduce involuntary churn.
CAC → LTV: sensitivity
Assumptions: price €69/month, gross margin 70%.
| Monthly churn | CAC | LTV (margin) | LTV:CAC |
|---|---|---|---|
| 4% (optimistic) | €50 | €1.207 | 24,2x |
| 7% (base) | €100 | €690 | 6,9x |
| 12% (stress) | €150 | €403 | 2,7x |
Channels and creative angles
- Meta (IG Reels/Stories): UGC, fitness/beauty creators
- Google Search: intent "personalized supplements"
- YouTube: long-form explainer + sports creators
- Affiliate / influencer performance
- Gym/box partnerships (sampling)
- "From 10 pills to 1 stick"
- Right forms (not cheap oxides) and consistent dosages
- Personalized: goals, diet, sport, stress, sleep
- Transparency: why these ingredients
Launch budget (90 days, Italy)
Next steps: 30–40 validation interviews, 2 ad tests to calibrate real CAC, and first cohort retention to demonstrate unit economics. In parallel, building the trust stack (COA, third-party tests, compliance claims) as a competitive barrier.